• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020年4月紧急状态声明发布时日本新冠肺炎患者的重症监护需求与重症监护供应情况:描述性分析

Critical Care Demand and Intensive Care Supply for Patients in Japan with COVID-19 at the Time of the State of Emergency Declaration in April 2020: A Descriptive Analysis.

作者信息

Fujii Yosuke, Hirota Kiichi

机构信息

Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Osaka 573-1010, Japan.

出版信息

Medicina (Kaunas). 2020 Oct 12;56(10):530. doi: 10.3390/medicina56100530.

DOI:10.3390/medicina56100530
PMID:33053765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7600748/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic is overwhelming Japan's intensive care capacity. This study aimed to determine the number of patients with COVID-19 who required intensive care and to compare the numbers with Japan's intensive care capacity. Publicly available datasets were used to obtain the number of confirmed patients with COVID-19 undergoing mechanical ventilation and extracorporeal membrane oxygenation (ECMO) between 15 February and 19 July 2020 to determine and compare intensive care unit (ICU) and attending bed needs for patients with COVID-19, and to estimate peak ICU demands in Japan. During the epidemic peak in late April, 11,443 patients (1.03/10,000 adults) had been infected, 373 patients (0.034/10,000 adults) were in ICU, 312 patients (0.028/10,000 adults) were receiving mechanical ventilation, and 62 patients (0.0056/10,000 adults) were under ECMO per day. At the peak of the epidemic, the number of infected patients was 651% of designated beds, and the number of patients requiring intensive care was 6.0% of ICU beds, 19.1% of board-certified intensivists, and 106% of designated medical institutions in Japan. The number of critically ill patients with COVID-19 continued to rise during the pandemic, exceeding the number of designated beds but not exceeding ICU capacity.

摘要

2019年冠状病毒病(COVID-19)大流行正使日本的重症监护能力不堪重负。本研究旨在确定需要重症监护的COVID-19患者数量,并将这些数字与日本的重症监护能力进行比较。利用公开可用的数据集获取2020年2月15日至7月19日期间接受机械通气和体外膜肺氧合(ECMO)的COVID-19确诊患者数量,以确定和比较COVID-19患者的重症监护病房(ICU)需求及床位需求,并估计日本ICU需求高峰。在4月下旬的疫情高峰期,每天有11443名患者(每10000名成年人中有1.03名)被感染,373名患者(每10000名成年人中有0.034名)在ICU,312名患者(每10000名成年人中有0.028名)接受机械通气,62名患者(每10000名成年人中有0.0056名)接受ECMO治疗。在疫情高峰期,感染患者数量是指定床位的651%,需要重症监护的患者数量是ICU床位的6.0%、日本有资质的重症医学专家的19.1%、指定医疗机构的106%。在大流行期间,COVID-19重症患者数量持续上升,超过了指定床位数量,但未超过ICU容量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/3d0122004e2e/medicina-56-00530-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/483a108fdfcb/medicina-56-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/21657bbc7eb1/medicina-56-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/cfb45dec9d89/medicina-56-00530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/3d0122004e2e/medicina-56-00530-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/483a108fdfcb/medicina-56-00530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/21657bbc7eb1/medicina-56-00530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/cfb45dec9d89/medicina-56-00530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cdd/7600748/3d0122004e2e/medicina-56-00530-g004.jpg

相似文献

1
Critical Care Demand and Intensive Care Supply for Patients in Japan with COVID-19 at the Time of the State of Emergency Declaration in April 2020: A Descriptive Analysis.2020年4月紧急状态声明发布时日本新冠肺炎患者的重症监护需求与重症监护供应情况:描述性分析
Medicina (Kaunas). 2020 Oct 12;56(10):530. doi: 10.3390/medicina56100530.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
Estimated Demand for US Hospital Inpatient and Intensive Care Unit Beds for Patients With COVID-19 Based on Comparisons With Wuhan and Guangzhou, China.基于与中国武汉和广州的比较,估计美国因 COVID-19 住院和重症监护病房床位的需求。
JAMA Netw Open. 2020 May 1;3(5):e208297. doi: 10.1001/jamanetworkopen.2020.8297.
4
Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.在纽约一家医院中对 4404 人进行的 COVID-19 调查队列研究,以及 ICU 护理和通气的预测因素。
Ann Emerg Med. 2020 Oct;76(4):394-404. doi: 10.1016/j.annemergmed.2020.05.011. Epub 2020 May 11.
5
Surge capacity of intensive care units in case of acute increase in demand caused by COVID-19 in Australia.澳大利亚因 COVID-19 导致对重症监护病房的需求急性增加时的重症监护病房容量。
Med J Aust. 2020 Jun;212(10):463-467. doi: 10.5694/mja2.50596. Epub 2020 Apr 19.
6
[Bed capacity management in times of the COVID-19 pandemic : A simulation-based prognosis of normal and intensive care beds using the descriptive data of the University Hospital Augsburg].[新冠疫情期间的床位容量管理:利用奥格斯堡大学医院的描述性数据对普通病房和重症监护病房床位进行基于模拟的预测]
Anaesthesist. 2020 Oct;69(10):717-725. doi: 10.1007/s00101-020-00830-6. Epub 2020 Aug 21.
7
[Intensive Care During a Global Epidemic].[全球疫情期间的重症监护]
Hu Li Za Zhi. 2020 Jun;67(3):4-5. doi: 10.6224/JN.202006_67(3).01.
8
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.意大利伦巴第大区新冠疫情期间的重症监护利用情况:应急响应中的早期经验与预测
JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.
9
Regional extracorporeal membrane oxygenation retrieval service during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic: an interdisciplinary team approach to maintain service provision despite increased demand.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行期间的区域性体外膜肺氧合检索服务:尽管需求增加,但仍采用跨学科团队方法维持服务提供。
Eur J Cardiothorac Surg. 2020 Nov 1;58(5):875-880. doi: 10.1093/ejcts/ezaa327.
10
Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan.武汉一家临时重症监护病房对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的重症监护。
Crit Care. 2020 May 6;24(1):199. doi: 10.1186/s13054-020-02914-6.

引用本文的文献

1
Japanese Multicenter Research of COVID-19 by Assembling Real-world Data: A Study Protocol.通过收集真实世界数据进行的日本 COVID-19 多中心研究:研究方案。
Ann Clin Epidemiol. 2022 Mar 11;4(3):92-100. doi: 10.37737/ace.22012. eCollection 2022.
2
Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.KL-6 对预测 COVID-19 住院患者临床结局的作用。
Medicina (Kaunas). 2022 Sep 21;58(10):1317. doi: 10.3390/medicina58101317.
3
Intensive Care Unit versus High-dependency Care Unit for COVID-19 Patients with Invasive Mechanical Ventilation.

本文引用的文献

1
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
2
Save the ICU and save lives during the COVID-19 pandemic.在新冠疫情期间拯救重症监护病房并拯救生命。
J Intensive Care. 2020 Jun 15;8:40. doi: 10.1186/s40560-020-00456-1. eCollection 2020.
3
Considerations for Oral and Maxillofacial Surgeons in COVID-19 Era: Can We Sustain the Solutions to Keep Our Patients and Healthcare Personnel Safe?
新冠肺炎患者有创机械通气患者入住重症加强护理病房与高依赖护理病房的比较。
Ann Am Thorac Soc. 2023 Jan;20(1):102-109. doi: 10.1513/AnnalsATS.202206-475OC.
4
Workforce and Task Sharing of Nurses in the Japanese Intensive Care Unit-Cross-Sectional Postal Survey.日本重症监护病房护士的劳动力与任务分担——横断面邮政调查
Healthcare (Basel). 2021 Aug 7;9(8):1017. doi: 10.3390/healthcare9081017.
5
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan.在日本的一项大型 COVID-19 患者队列中,入院时严重程度和住院期间疾病进展的危险因素。
BMJ Open. 2021 Jun 15;11(6):e047007. doi: 10.1136/bmjopen-2020-047007.
COVID-19 时代口腔颌面外科医生的考量:我们能否持续保持让患者和医护人员安全的解决方案?
J Oral Maxillofac Surg. 2020 Aug;78(8):1241-1256. doi: 10.1016/j.joms.2020.05.027. Epub 2020 May 24.
4
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
5
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
6
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
7
Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report.体外膜肺氧合(ECMO)成功救治新型冠状病毒肺炎(COVID-19)呼吸衰竭一例报告
Patient Saf Surg. 2020 May 8;14:20. doi: 10.1186/s13037-020-00245-7. eCollection 2020.
8
[Tracheal intubation in patients with severe and critical COVID-19: analysis of 18 cases].[新型冠状病毒肺炎重型、危重型患者气管插管:18例分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Mar 30;40(3):337-341. doi: 10.12122/j.issn.1673-4254.2020.03.07.
9
Estimated Demand for US Hospital Inpatient and Intensive Care Unit Beds for Patients With COVID-19 Based on Comparisons With Wuhan and Guangzhou, China.基于与中国武汉和广州的比较,估计美国因 COVID-19 住院和重症监护病房床位的需求。
JAMA Netw Open. 2020 May 1;3(5):e208297. doi: 10.1001/jamanetworkopen.2020.8297.
10
Consideration of the Aerosol Transmission for COVID-19 and Public Health.考虑 COVID-19 的气溶胶传播和公共卫生。
Risk Anal. 2020 May;40(5):902-907. doi: 10.1111/risa.13500. Epub 2020 May 1.